Increased Risk of Non-Alcoholic Steatohepatitis in Patients With Inflammatory Bowel Disease: A Population-Based Study

Abstract

Background and objectiveThe global health burden of inflammatory bowel disease (IBD) stems from its increasing incidence over the years. Comprehensive studies on the topic hypothesize that IBD plays a more dominant in the development of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). In light of this, we conducted this study with the aim of assessing the prevalence and risk factors of developing NASH in patients who have had a diagnosis of ulcerative colitis (UC) and Crohn's disease (CD). MethodologyA validated multicenter and research platform database of more than 360 hospitals from 26 different healthcare systems across the United States from 1999 to September 2022 was utilized for conducting this study. Patients aged 18-65 years were included. Pregnant patients and individuals diagnosed with alcohol use disorder were excluded. The risk of developing NASH was calculated using a multivariate regression analysis to account for potential confounding variables including male gender, hyperlipidemia, hypertension, type 2 diabetes mellitus (T2DM), and obesity. A two-sided p-value <0.05 was considered statistically significant, and all statistical analyses were performed using R version 4.0.2 (R Foundation for Statistical Computing, Vienna, Austria, 2008). ResultsA total of 79,346,259 individuals were screened in the database and 46,667,720 were selected for the final analysis based on the inclusion and exclusion criteria. Using multivariate regression analysis, the risk of developing NASH among patients with UC and CD was calculated. The odds of having NASH among patients with UC was 2.37 (95% CI: 2.17-2.60, p<0.001). Similarly, the odds of having NASH were high in patients with CD as well, at 2.79 (95% CI: 2.58-3.02, p<0.001). ConclusionBased on our findings, patients with IBD have an increased prevalence and higher odds of developing NASH after controlling for common risk factors. We believe that a complex pathophysiological relationship exists between both disease processes. Further research is required to establish appropriate screening times to enable earlier disease identification and thereby improve patient outcomes.

Arab world’s impact on bladder cancer research and opportunities for growth: A bibliometric review study

“…These developments, in conjunction with advancements in surgical and intravesical treatment methods, are expected to lead to improved patient outcomes. [ 31 ] Through the use of genomics, the classification of the disease pathology has been improved, resulting in pathology-specific management strategies and more accurate prognostic evaluations. [ 32 , 33 ] However, the identification of genetic and other biomarkers that would allow for tailored management is still an area of ongoing research.…”

Prevalence and Risk Factors Associated with Upper Gastrointestinal Malignancies in Post-Menopausal Patients on Hormone Replacement Therapy: A Population-Based Study

“…The Institutional Review Board is not required because Explorys is a platform that complies with the Health Insurance Portability and Accountability Act (HIPAA). The use of this database has been approved in a number of specialties, including gastroenterology, hematology, and cardiology [7][8][9][10][11].…”

Endoplasmic reticulum stress: A possible connection between intestinal inflammation and neurodegenerative disorders

“…Finally, an emerging role in this context would be related to lipid metabolism and the interplay between intestinal inflammation, lipid storage, and misfolded protein aggregation. IBD and intestinal inflammation are associated to an increased risk of liver steatosis and nonalcoholic fatty liver disease 186,187 . In turn, liver steatosis is associated to ER stress, mitochondrial dysfunction as well as accumulation of intracellular lipids droplets and misfolded proteins 188,189 .…”

“…IBD and intestinal inflammation are associated to an increased risk of liver steatosis and nonalcoholic fatty liver disease. 186,187 In turn, liver steatosis is associated to ER stress, mitochondrial dysfunction as well as accumulation of intracellular lipids droplets and misfolded proteins. 188,189 Although very few studies have explored the role of the liver in neurodegenerative disorders, it is important to underline that α-syn accumulates in the liver in course of PD, resulting in inflammatory infiltration and hepatocytes reorganization.…”